Sort   by:  
 Page size 
TranscriptomicsSingle-cell RNA-seq of the human fetal lateral ganglionic eminence at 7, 9 and 11 post-conceptional weeks
Single-cell RNA-seq of the LGE between 7 and 11 pcw was used to uncover the different cell populations of the developing human striatum and how cells transition from early progenitors to mature medium spiny neuron (MSNs) together with the discovery of their unique coding and non-coding transcription...
ORGANISM(S): Homo sapiens 
2021-05-13 | E-MTAB-8894 | biostudies-arrayexpress
UnknownNo major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort.
Not available
S-EPMC3511779 | biostudies-literature
UnknownSARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Not available
S-EPMC9874469 | biostudies-literature
UnknownAltered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease.
Not available
S-EPMC10572781 | biostudies-literature
UnknownCOVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies.
Not available
S-EPMC8444788 | biostudies-literature
UnknownAnti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study.
Not available
S-EPMC12031816 | biostudies-literature
TranscriptomicsBulk RNA-seq of the human fetal neocortex, lateral ganglionic eminence and medial ganglionic eminence at 7, 9, 11 and 20 post-conceptional weeks
Deep transcriptional profiling of the human neocortex, lateral ganglionic eminence (LGE) and medial ganglionic eminences (MGE), from 7 to 20 post-conceptional weeks (pcw), for de novo lincRNAs discovery and to establish a unique coding and non-coding gene signature for the three different regions.
ORGANISM(S): Homo sapiens 
2021-05-13 | E-MTAB-8893 | biostudies-arrayexpress
UnknownThe new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
Not available
S-EPMC10798925 | biostudies-literature
UnknownPerspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
Not available
S-EPMC8189147 | biostudies-literature
UnknownTreatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study.
Not available
S-EPMC10076530 | biostudies-literature
Sort   by:  
 Page size